Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

It was a good week for startups looking to raise big, as two companies raised rounds of well more than a half-billion dollars ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has ...

Coinbase CEO Brian Armstrong believes this situation can be reversed, and says a health startup he cofounded is making faster ...

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...